AWAK Technologies (AWAK), a pioneering medical technology company developing a wearable dialysis product and other complementary solutions for chronic kidney disease (CKD) management, today announced that its kidney disease progression prediction (KDPP) Artificial Intelligence (AI) model for CKD patient care has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA). The KDPP model helps to assess the risk of kidney disease progression and initiation of renal

Related Keywords

California , United States , China , Taiwan , India , Bengaluru , Karnataka , Singapore , Priyanka Arya , Mandar Gori , Chin Chi Kuo , Suresha Venkataraya , Abel Ang , Los Angeles , Technologies Pte Ltd , China Medical University Hospital , Fortune Ai Co , Academic Medical Centre , Fever Fortune , Breakthrough Device , Chief Executive Officer , Medical Consultant , Singapore General Hospital , Chief Business Officer , Breakthrough Device Designation , Asia Based Medtech , General Hospital , Artificial Intelligence , Kidney Disease , Fwak , Food And Drug Administration , Resignation ,